Alan Williams
Geschäftsführer bei Adela, Inc.
Aktive Positionen von Alan Williams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Adela, Inc.
 Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Geschäftsführer | 11.05.2023 | - |
Karriereverlauf von Alan Williams
Ehemalige bekannte Positionen von Alan Williams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STANDARD BIOTOOLS INC. | Corporate Officer/Principal | 01.01.2020 | 01.03.2023 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01.02.2014 | 01.04.2015 |
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01.03.2009 | 01.03.2010 |
Ausbildung von Alan Williams
| University of California, Davis | Undergraduate Degree |
| University of California, Riverside | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| STANDARD BIOTOOLS INC. | Commercial Services |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Adela, Inc.
Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |
- Börse
- Insiders
- Alan Williams
- Erfahrung
